Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126812481 | 12681248 | 1 | I | 201603 | 20160815 | 20160824 | 20160824 | EXP | GB-MHRA-MIDB-0EAE1047-90E4-4DCB-A159-EA7A765D21A3 | GB-SA-2016SA149954 | AVENTIS | 81.00 | YR | E | Y | 0.00000 | 20160824 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126812481 | 12681248 | 1 | PS | CLOPIDOGREL BISULFATE. | CLOPIDOGREL BISULFATE | 1 | Unknown | UNK | 20839 | 75 | MG | QD | |||||||
| 126812481 | 12681248 | 2 | SS | ASPIRIN. | ASPIRIN | 1 | Unknown | 1575 | MG | Y | UNK | 0 | 75 | MG | QD | ||||
| 126812481 | 12681248 | 3 | SS | WARFARIN | WARFARIN | 1 | Unknown | AS DIRECTED BY DOCTOR. | Y | UNK | 0 | ||||||||
| 126812481 | 12681248 | 4 | C | AMIODARONE | AMIODARONE | 1 | 0 | 100 | MG | QD | |||||||||
| 126812481 | 12681248 | 5 | C | BISOPROLOL | BISOPROLOL | 1 | 0 | 2.5 | MG | QD | |||||||||
| 126812481 | 12681248 | 6 | C | GLYCERYL TRINITRATE | NITROGLYCERIN | 1 | AS NEEDED. | 0 | |||||||||||
| 126812481 | 12681248 | 7 | C | ISOSORBIDE MONONITRATE. | ISOSORBIDE MONONITRATE | 1 | 0 | 120 | MG | QD | |||||||||
| 126812481 | 12681248 | 8 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 0 | 30 | MG | QD | |||||||||
| 126812481 | 12681248 | 9 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | 50 | UG | QD | |||||||||
| 126812481 | 12681248 | 10 | C | RANOLAZINE | RANOLAZINE | 1 | 0 | 500 | MG | BID | |||||||||
| 126812481 | 12681248 | 11 | C | SALBUTAMOL | ALBUTEROL | 1 | PUFF. | 0 | 2 | DF | TID | ||||||||
| 126812481 | 12681248 | 12 | C | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | PUFF. | 0 | 1 | DF | BID | ||||||||
| 126812481 | 12681248 | 13 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 | 20 | MG | QD |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126812481 | 12681248 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126812481 | 12681248 | Dizziness | |
| 126812481 | 12681248 | Duodenitis | |
| 126812481 | 12681248 | Gastrointestinal haemorrhage | |
| 126812481 | 12681248 | Haemoglobin decreased | |
| 126812481 | 12681248 | Hyperhidrosis | |
| 126812481 | 12681248 | Malaise | |
| 126812481 | 12681248 | Melaena | |
| 126812481 | 12681248 | Microcytic anaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126812481 | 12681248 | 2 | 20160322 | 0 |